IMPLEMENTATION STUDY OF THE USE OF A BLOOD BIOMARKER TEST IN ALZHEIMER'S DISEASE: CLINICIAN SURVEY FROM QUIP II STUDY

被引:0
|
作者
Monane, Mark [1 ]
Carlile, Robert [2 ]
Johnson, Kim [3 ]
Gitelman, Darren [4 ]
VandeVrede, Lawren [5 ]
Jacobs, Leslie [1 ]
Braunstein, Joel [1 ]
机构
[1] C2 N DIagnost, St Louis, MO USA
[2] Palmetto Primary Care Phys, Summerville, SC USA
[3] Duke Univ, Durham, NC USA
[4] Advocate Lutheran Gen Hosp, Park Ridge, IL USA
[5] UCSF, San Francisco, CA USA
关键词
D O I
10.1093/geroni/igae098.4301
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
igae098.43
引用
收藏
页码:1348 / 1348
页数:1
相关论文
共 50 条
  • [1] Clinical Utility of an Alzheimer's Disease Blood Test Among Cognitively Impaired Patients: Results from the Quality Improvement PrecivityAD2 (QUIP II) Clinician Survey Study
    Monane, Mark
    Maraganore, Demetrius M.
    Carlile, Robert M.
    Johnson, Kim G.
    Merrill, David A.
    Gitelman, Darren R.
    Sharlin, Kenneth S.
    Vandevrede, Lawren A.
    George, Kristi K.
    Wang, Jimin
    West, Tim
    Jacobs, Leslie
    Verghese, Philip B.
    Braunstein, Joel B.
    DIAGNOSTICS, 2025, 15 (02)
  • [2] Blood Amyloid-β Oligomerization as a Biomarker of Alzheimer's Disease: A Blinded Validation Study
    Youn, Young Chul
    Lee, Byoung Sub
    Kim, Gwang Je
    Ryu, Ji Sun
    Lim, Kuntaek
    Lee, Ryan
    Suh, Jeewon
    Park, Young Ho
    Pyun, Jung-Min
    Ryu, Nayoung
    Kang, Min Ju
    Kim, Hye Ryoun
    Kang, Sungmin
    An, Seong Soo A.
    Kim, SangYun
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 75 (02) : 493 - 499
  • [3] Systematic Analysis and Biomarker Study for Alzheimer's Disease
    Li, Xinzhong
    Wang, Haiyan
    Long, Jintao
    Pan, Genhua
    He, Taigang
    Anichtchik, Oleg
    Belshaw, Robert
    Albani, Diego
    Edison, Paul
    Green, Elaine K.
    Scott, James
    SCIENTIFIC REPORTS, 2018, 8
  • [4] Systematic Analysis and Biomarker Study for Alzheimer’s Disease
    Xinzhong Li
    Haiyan Wang
    Jintao Long
    Genhua Pan
    Taigang He
    Oleg Anichtchik
    Robert Belshaw
    Diego Albani
    Paul Edison
    Elaine K Green
    James Scott
    Scientific Reports, 8
  • [5] Clinician's perspectives on gene therapy for Alzheimer's disease: A qualitative study
    Kelemen, Lilly
    Gupta, Ishika
    Yavarow, Zollie
    Smith, Samantha I.
    Johnson, Kim G.
    Boucher, Nathan A.
    PLOS ONE, 2024, 19 (07):
  • [6] Ethical considerations of biomarker use in neurodegenerative diseases-A case study of Alzheimer's disease
    Prvulovic, David
    Hampel, Harald
    PROGRESS IN NEUROBIOLOGY, 2011, 95 (04) : 517 - 519
  • [7] Multicenter Alzheimer's and Parkinson's disease immune biomarker verification study
    Brosseron, Frederic
    Kolbe, Carl-Christian
    Santarelli, Francesco
    Carvalho, Stephanie
    Antonell, Anna
    Castro-Gomez, Sergio
    Tacik, Pawel
    Namasivayam, Aishwarya Alex
    Mangone, Graziella
    Schneider, Reinhard
    Latz, Eicke
    Wuellner, Ullrich
    Svenningsson, Per
    Sanchez-Valle, Raquel
    Luis Molinuevo, Jose
    Corvol, Jean-Christophe
    Heneka, Michael T.
    ALZHEIMERS & DEMENTIA, 2020, 16 (02) : 292 - 304
  • [8] The study of circulating biomarker panels in early diagnosis of Alzheimer's disease
    Zhou, Wen-xia
    Jiang, Ning
    Ruan, Can-Jun
    Cheng, Xiao-rui
    Zhang, Yong-xiang
    FASEB JOURNAL, 2017, 31
  • [9] Study rules out zinc as a potential biomarker of Alzheimer's disease
    Potticary, James
    BIOANALYSIS, 2014, 6 (12) : 1582 - 1582
  • [10] Clinical and biomarker trajectories in sporadic Alzheimer's disease: A longitudinal study
    Wang, Hui-Fu
    Shen, Xue-Ning
    Li, Jie-Qiong
    Suckling, John
    Tan, Chen-Chen
    Wang, Yan-Jiang
    Feng, Lei
    Zhang, Can
    Tan, Lan
    Dong, Qiang
    Touchon, Jacques
    Gauthier, Serge
    Yu, Jin-Tai
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2020, 12 (01)